மல்டிபிள் ஸ்களீரோசிஸ் ஜர்னல்

Cognitive Decline in Older Multiple Sclerosis Patients

Jin Yong

Two-year Assessment of the Efficacy and Safety of Ocrelizumab in Switching Patients from Other Disease Modifying Therapies

Terzi Murat, Boz Cavit, Demir Caner Feyzi, Cilingir Vedat, Helvaci Elif Merve